Your browser doesn't support javascript.
loading
Inhibition of ocular neovascularization by novel anti-angiogenic compound.
Gau, David; Vignaud, Lucile; Francoeur, Paul; Koes, David; Guillonneau, Xavier; Roy, Partha.
Affiliation
  • Gau D; Bioengineering, University of Pittsburgh, USA.
  • Vignaud L; Sorbonne Université, INSERM, Institut de la Vision, Paris, France.
  • Francoeur P; Computational Biology, University of Pittsburgh, USA.
  • Koes D; Computational Biology, University of Pittsburgh, USA.
  • Guillonneau X; Sorbonne Université, INSERM, Institut de la Vision, Paris, France.
  • Roy P; Bioengineering, University of Pittsburgh, USA; Pathology, University of Pittsburgh, USA. Electronic address: par19@pitt.edu.
Exp Eye Res ; 213: 108861, 2021 12.
Article in En | MEDLINE | ID: mdl-34822853
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinal Neovascularization / Choroidal Neovascularization / Angiogenesis Inhibitors Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Exp Eye Res Year: 2021 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinal Neovascularization / Choroidal Neovascularization / Angiogenesis Inhibitors Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Exp Eye Res Year: 2021 Document type: Article Affiliation country: